In vitro effects of 2-methoxyestradiol on morphology, cell cycle progression, cell death and gene expression changes in the tumorigenic MCF-7 breast epithelial cell line

Journal of Steroid Biochemistry and Molecular Biology

Volumn 119, Issue 3-5, 2010, Pages 149-160

  Stander, B A ^a   Marais, S ^a   Vorster, C J J ^a   Joubert, A M ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

2 Methoxyestradiol; Apoptosis; Autophagy; MCF 7

Indexed keywords

2 METHOXYESTRADIOL; ACRIDINE ORANGE; CYCLIN B; CYTOCHROME C; HOE 33342; HYDROGEN PEROXIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE; MOLECULAR DYNAMICS; RNA TRANSLATION; STAINING; TRANSMISSION ELECTRON MICROSCOPY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CASPASE 3; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL SHAPE; CYCLIN B1; CYTOCHROMES C; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; VACUOLES;

EID: 77950224904     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.019     Document Type: Article

References (71)

1. Mooberry S.L. Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist. Update 2003, 6(6):355-361.
2. Newman S.P., Ireson C.R., Tutill H.J., Day J.M., Parsons M.F., Leese M.P., Potter B.V., Reed M.J., Purohit A. The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Cancer Res. 2006, 66(1):324-330.
3. Matei D., Schilder J., Sutton G., Perkins S., Breen T., Quon C., Sidor C. Activity of 2-methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial. Gynecol. Oncol. 2009, 115(1):90-96.
4. Fogler W.E., Volker K.M., Swartz G.M., Plum S.M., Strawn S.J., LaVallee T.M., Sidor C.F., Treston A.M. The antitumor activity of 2-methoxyestradiol is maximized by maintaining a threshold concentration over a 24-hour dosing interval. Proceedings of the AACR-NCIEORTC International Conference on Molecular Targets and Cancer Therapeutics, vol. 173 2005, B180.
5. Tevaarwerk A.J., Holen K.D., Alberti D.B., Sidor C., Arnott J., Quon C., Wilding G., Liu G. Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies. Clin. Cancer Res. 2009, 15(4):1460-1465.
6. Bhati R., Gokmen-Polar Y., Sledge G.W., Fan C., Nakshatri H., Ketelsen D., Borchers C.H., Dial M.J., Patterson C., Klauber-DeMore N. 2-Methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells. Cancer Res. 2007, 67(2):702-708.
7. Dubey R.K., Jackson E.K. Potential vascular actions of 2-methoxyestradiol. Trends Endocrinol. Metab. 2009, 20(8):374-379.
8. Mabjeesh N.J., Escuin D., LaVallee T.M., Pribluda V.S., Swartz G.M., Johnson M.S., Willard M.T., Zhong H., Simons J.W., Giannakakou P. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003, 3(4):363-375.
9. Kamath K., Okouneva T., Larson G., Panda D., Wilson L., Jordan M.A. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules. Mol. Cancer Ther. 2006, 5(9):2225-2233.
10. Zoubine M.N., Weston A.P., Johnson D.C., Campbell D.R., Banerjee S.K. 2-Methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression. Int. J. Oncol. 1999, 15(4):639-646.
11. Van Zijl C., Lottering M.L., Steffens F., Joubert A. In vitro effects of 2-methoxyestradiol on MCF-12A and MCF-7 cell growth, morphology and mitotic spindle formation. Cell Biochem. Funct. 2008, 26(5):632-642.
12. Lewis J.S., Thomas T.J., Pestell R.G., Albanese C., Gallo M.A., Thomas T. Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. J. Mol. Endocrinol. 2005, 34(1):91-105.
13. Fukui M., Zhu B.T. Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Mol. Carcinog. 2009, 48(1):66-78.
14. LaVallee T.M., Zhan X.H., Johnson M.S., Herbstritt C.J., Swartz G., Williams M.S., Hembrough W.A., Green S.J., Pribluda V.S. 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res. 2003, 63(2):468-475.
15. Rae J.M., Creighton C.J., Meck J.M., Haddad B.R., Johnson M.D. MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 2007, 104(1):13-19.
16. Joubert A., Maritz C., Joubert F. Bax/Bcl-2 expression levels of 2-methoxyestradiol-exposed esophageal cancer cells. Biomed Res. 2005, 26(3):131-134.
17. Joubert A., Maritz C., Joubert F. Influence of prostaglandin A2 and 2-methoxyestradiol on Bax and Bcl-2 expression levels in cervical carcinoma cells. Biomed Res. 2005, 26(2):87-90.
18. Bu S.Z., Huang Q., Jiang Y.M., Min H.B., Hou Y., Guo Z.Y., Wei J.F., Wang J.W., Ni X., Zheng S.S. p38 Mitogen-activated protein kinases is required for counteraction of 2-methoxyestradiol to estradiol-stimulated cell proliferation and induction of apoptosis in ovarian carcinoma cells via phosphorylation Bcl-2. Apoptosis 2006, 11(3):413-425.
19. Bu S., Blaukat A., Fu X., Heldin N.E., Landstrom M. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett. 2002, 531(2):141-151.
20. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 1998, 273(16):9357-9360.
21. Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J. Leukoc. Biol. 1990, 47(5):440-448.
22. Zhao H., Kalivendi S., Zhang H., Joseph J., Nithipatikom K., Vasquez-Vivar J., Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic. Biol. Med. 2003, 34(11):1359-1368.
23. Klionsky D.J., Cuervo A.M., Seglen P.O. Methods for monitoring autophagy from yeast to human. Autophagy 2007, 3(3):181-206.
24. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. (Article 3).
25. Wettenhall J.M., Smyth G.K. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 2004, 20(18):3705-3706.
26. Ritchie M.E., Silver J., Oshlack A., Holmes M., Diyagama D., Holloway A., Smyth G.K. A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007, 23(20):2700-2707.
27. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31(4):265-273.
28. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Methodol.) 1995, 57(1):289-300.
29. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Prot. 2009, 4(1):44-57.
30. Carmona-Saez P., Chagoyen M., Tirado F., Carazo J.M., Pascual-Montano A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 2007, 8(1):R3.
31. Funahashi A., Morohashi M., Kitano H., Tanimura N. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. Biosilico 2003, 1(5):159-162.
32. Attalla H., Makela T.P., Adlercreutz H., Andersson L.C. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem. Biophys. Res. Commun. 1996, 228(2):467-473.
33. Logarinho E., Resende T., Torres C., Bousbaa H. The human spindle assembly checkpoint protein Bub3 is required for the establishment of efficient kinetochore-microtubule attachments. Mol. Biol. Cell 2008, 19(4):1798-1813.
34. Bharadwaj R., Qi W., Yu H. Identification of two novel components of the human NDC80 kinetochore complex. J. Biol. Chem. 2004, 279(13):13076-13085.
35. van der Voet M., Berends C.W., Perreault A., Nguyen-Ngoc T., Gonczy P., Vidal M., Boxem M., van den Heuvel S. NuMA-related LIN-5, ASPM-1, calmodulin and dynein promote meiotic spindle rotation independently of cortical LIN-5/GPR/Galpha. Nat. Cell. Biol. 2009, 11(3):269-277.
36. Yardimci H., van Duffelen M., Mao Y., Rosenfeld S.S., Selvin P.R. The mitotic kinesin CENP-E is a processive transport motor. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(16):6016-6021.
37. Cho J.H., Chang C.J., Chen C.Y., Tang T.K. Depletion of CPAP by RNAi disrupts centrosome integrity and induces multipolar spindles. Biochem. Biophys. Res. Commun. 2006, 339(3):742-747.
38. Zhang P., Cong B., Yuan H., Chen L., Lv Y., Bai C., Nan X., Shi S., Yue W., Pei X. Overexpression of spindlin1 induces metaphase arrest and chromosomal instability. J. Cell. Physiol. 2008, 217(2):400-408.
39. Lew D.J., Burke D.J. The spindle assembly and spindle position checkpoints. Annu. Rev. Genet. 2003, 37:251-282.
40. Baker D.J., Dawlaty M.M., Galardy P., van Deursen J.M. Mitotic regulation of the anaphase-promoting complex. Cell Mol. Life Sci. 2007, 64(5):589-600.
41. Yu H. Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin. Cell Biol. 2002, 14(6):706-714.
42. Peters J.M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol. 2006, 7(9):644-656.
43. Kramer E.R., Scheuringer N., Podtelejnikov A.V., Mann M., Peters J.M. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol. Biol. Cell 2000, 11(5):1555-1569.
44. Zhou N.N., Zhu X.F., Zhou J.M., Li M.Z., Zhang X.S., Huang P., Jiang W.Q. 2-Methoxyestradiol induces cell cycle arrest and apoptosis of nasopharyngeal carcinoma cells. Acta Pharmacol. Sin. 2004, 25(11):1515-1520.
45. Lis A., Ciesielski M.J., Barone T.A., Scott B.E., Fenstermaker R.A., Plunkett R.J. 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett. 2004, 213(1):57-65.
46. Li L., Bu S., Backstrom T., Landstrom M., Ulmsten U., Fu X. Induction of apoptosis and G2/M arrest by 2-methoxyestradiol in human cervical cancer HeLaS3 cells. Anticancer Res. 2004, 24(2B):873-880.
47. Lindqvist A., van Zon W., Karlsson Rosenthal C., Wolthuis R.M. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression. PLoS Biol. 2007, 5(5):e123.
48. Uhlmann F., Lottspeich F., Nasmyth K. Sister-chromatid separation at anaphase onset is promoted by cleavage of the cohesin subunit Scc1. Nature 1999, 400(6739):37-42.
49. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
50. Gao N., Rahmani M., Dent P., Grant S. 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 2005, 24(23):3797-3809.
51. She M.R., Li J.G., Guo K.Y., Lin W., Du X., Niu X.Q. Requirement of reactive oxygen species generation in apoptosis of leukemia cells induced by 2-methoxyestradiol. Acta Pharmacol. Sin. 2007, 28(7):1037-1044.
52. Chen Y., McMillan-Ward E., Kong J., Israels S.J., Gibson S.B. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008, 15(1):171-182.
53. Culotta V.C., Yang M., O'Halloran T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim. Biophys. Acta 2006, 1763(7):747-758.
54. Kachadourian R., Liochev S.I., Cabelli D.E., Patel M.N., Fridovich I., Day B.J. 2-Methoxyestradiol does not inhibit superoxide dismutase. Arch. Biochem. Biophys. 2001, 392(2):349-353.
55. Crooke P.S., Ritchie M.D., Hachey D.L., Dawling S., Roodi N., Parl F.F. Estrogens, enzyme variants, and breast cancer: a risk model. Cancer Epidemiol. Biomarkers Prev. 2006, 15(9):1620-1629.
56. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 2007, 19(9):1807-1819.
57. Djavaheri-Mergny M., Wietzerbin J., Besancon F. 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 2003, 22(17):2558-2567.
58. Orrenius S., Gogvadze V., Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 2007, 47:143-183.
59. Amendola R., Cervelli M., Fratini E., Polticelli F., Sallustio D.E., Mariottini P. Spermine metabolism and anticancer therapy. Curr. Cancer Drug Targets 2009, 9(2):118-130.
60. Wang Y., Casero R.A. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both?. J. Biochem. 2006, 139(1):17-25.
61. 2 in polyamine analogue-treated human breast cancer cell lines. J. Biol. Chem. 2005, 280(48):39843-39851.
62. Amendola R., Bellini A., Cervelli M., Degan P., Marcocci L., Martini F., Mariottini P. Direct oxidative DNA damage, apoptosis and radio sensitivity by spermine oxidase activities in mouse neuroblastoma cells. Biochim. Biophys. Acta 2005, 1755(1):15-24.
63. Keyse S.M., Tyrrell R.M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. U.S.A. 1989, 86(1):99-103.
64. Ryter S.W., Si M., Lai C.C., Su C.Y. Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. Am. J. Physiol. Heart Circ. Physiol. 2000, 279(6):H2889-2897.
65. Liochev S.I., Fridovich I. The Haber-Weiss cycle-70 years later: an alternative view. Redox Rep. 2002, 7(1):55-57. (author reply 59-60).
66. Kadowaki M., Karim M.R., Carpi A., Miotto G. Nutrient control of macroautophagy in mammalian cells. Mol. Aspects Med. 2006, 27(5-6):426-443.
67. Azad M.B., Chen Y., Gibson S.B. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid. Redox Signal. 2008.
68. Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 2005, 8(3):179-183.
69. Hudson C.C., Liu M., Chiang G.G., Otterness D.M., Loomis D.C., Kaper F., Giaccia A.J., Abraham R.T. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol. Cell Biol. 2002, 22(20):7004-7014.
70. Jiang B.H., Liu L.Z. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv. Cancer Res. 2009, 102:19-65.
71. Kagawa S., Gu J., Honda T., McDonnell T.J., Swisher S.G., Roth J.A., Fang B. Deficiency of caspase-3 in MCF7 cells blocks Bax-mediated nuclear fragmentation but not cell death. Clin. Cancer Res. 2001, 7(5):1474-1480.